Camelot Portfolios’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500
Closed -$129K 407
2025
Q4
$129K Buy
+500
New +$114K 0.08% 216
2024
Q3
Sell
-500
Closed -$94.1K 399
2024
Q2
$94.1K Buy
+500
New +$92.7K 0.05% 258

Other funds holding MSGS

Camelot Portfolios's MSGS Position: Q1 2026 in Review

Camelot Portfolios sold out of Madison Square Garden (MSGS) in Q1 2026, closing a stake of 500 shares — an estimated $129K sold.

Camelot Portfolios first reported a position in MSGS in Q2 2024 and held it in 2 quarters. The position peaked at $129K in Q4 2025. 410 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

  • Camelot Portfolios reported no remaining Madison Square Garden position as of Q1 2026 after selling out during the quarter.
  • Camelot Portfolios sold 500 Madison Square Garden shares in Q1 2026, an estimated $129K.
  • Camelot Portfolios first reported a position in Madison Square Garden in Q2 2024 and held it in 2 quarters.
  • Camelot Portfolios's Madison Square Garden position peaked at $129K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.